3 Reasons to Attend EASD’s Annual Meeting in 2017

The European Association for the Study of Diabetes (EASD) was founded in 1965 as non-profit, medical scientific association based in Duesseldorf, Germany. The Association’s main goal is to support and encourage research in the field of diabetes.

EASD has more than 5,000 active members from over 100 countries worldwide which makes it  one of the largest networks for diabetologists across the globe. Its Annual Meeting is held in a different European city each year. In 2017, the 53rd Annual Meeting of the European Association for the Study of Diabetes will take place in Lisbon, between 11-15 September 2017.

Is the 53rd Annual Meeting of the European Association for the Study of Diabetes on your list in 2017 or/ and 2018? Give us a sign and we’ll handle your accommodation needs in a fast and reliable way!

For 2017.

For 2018.

 

EASD’s Annual Meeting is the Biggest Event of Its Kind

Over 15,000 delegates from more than 130 countries are attending EASD’s Annual Meeting every year. The scientific programme includes over 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field. The Annual Meeting represents a great opportunity for physicians to learn more about diabetes and related diseases, for pharma companies to promote their products and for hotel brokers to showcase their offers. The event is a great opportunity to encounter new vendors and suppliers at the trade show exhibit hall.

 

The Programme Tackles the Hottest Topics in the Field

We’ve visited the event’s website and went through their Programme at a Glance section for the 2017 Annual Meeting. Some key topics that will approached during this year’s event are the following:

  • Management of type 2 diabetes with basal insulin revisited: results of the glargine 300 U/ml Real Life Study Program
  • Cardiovascular complications of diabetes: hot topics
  • Intergenerational transmission of obesity and diabetes: Is the fog being cleared?
  • The beta cell in type 2 diabetes: What are the changes and are they reversible?
  • Molecular transducers of metabolic benefits of exercise
  • Diabetes, obesity, their treatment and cancer risk: smoke or fire?
  • Cognitive impairment and Alzheimer’s disease in the type 2 diabetes patient: from basic science to treatment
  • Genome editing principle and practice: Is there opportunity for diabetes?

 

It’s a Great Opportunity to Visit Lisbon

Successful people know how to mix business with pleasure. It would be a pity to be in Lisbon for the 53rd Annual Meeting of the European Association for the Study of Diabetes and not visit this wonderful city.

Lisbon is Europe’s second oldest capital, predating other modern European capitals such as London, Paris and Rome by centuries. Lisbon is also where the world’s first diabetes association was created in 1926 by Ernesto Roma. You will be enchanted by its rich history, great architecture, old monuments and wonderful landscape. Lisbon is surrounded by beaches, mountains and the countryside. The view is amazing!

Here’s a list with some of the things that you can visit in Lisbon:

  • Saint George’s Castle, a major landmark that can be seen from anywhere in the city.
  • Jerónimos Monastery, a monastery of the military Order of Saint Jerome, an outstanding example of late-Gothic Manueline architecture and is a UNESCO site.
  • Belém Tower, a defense tower completed in 1520 during the reign of Manuel I.
  • Time Out Market Lisboa, home to 35 permanent stalls from some of Lisbon’s most celebrated foodie shops and restaurants.
  • Lisbon Oceanarium, the largest indoor aquarium in Europe.

 

That being said, we hope you’ll enjoy attending EASD’s Annual Meeting in 2017!

Contact us for a personalized accommodation offer for the 53rd Annual Meeting of the European Association for the Study of Diabetes. No strings attached. We usually reply within a few hours.

For 2017.

For 2018.

Advertisements

3 Big Challenges/ Issues Facing the MICE Industry

This article is brought to you by Congress Bookers, a reliable accommodation partner for lead pharma companies worldwide.

miceThe MICE – Meetings, Incentive, Conferences and Exhibitions – industry, however, is one of the main drivers within the tourism industry and has witnessed important growth over the past years. As the demand for meetings, incentives, congresses and events is on the rise, the MICE sector’s future looks bright. However, as things grow, challenges arise. For example, for MICE hotels, one of today’s greatest challenges is retaining a share in the increasingly competitive marketplace and this competitiveness poses issues on every sector of the MICE industry. Some of the biggest challenges are the following:

 

Virtual Meetings vs. Destination Meetings

virtualeventtechnology

Virtual meetings are like the fast food versions of destination meetings. Although the latter are more valuable since they provide engagement opportunities with pertinent topics without any distractions, virtual meetings are appealing because they allow you to attend without having to book a hotel room, get on a plane or leave your office chair. Of course, since they don’t involve booking rooms and buying plane tickets, virtual meetings are oftentimes cheaper than destination meetings. At the end of the day, there is value in both. Sometimes you can’t miss out on the huge networking opportunities during an event and you choose to go there in-person, other times you’re just interested in a topic and attend a virtual conference. However, planning for both and trying to appeal to both types of attendees is something the MICE industry will have to work on and it won’t be an easy task.

 

Keeping up with Technology

technology

Technology is evolving at an incredibly fast pace and, as this happens, event attendees’ expectations become higher. They want to be able to book hotel rooms, plane tickets, event access with minimum hassle, at the time of their convenience and on the device they’re using.

On the other hand, hotels need to keep up and improve their technologies to streamline communications and logistics with meeting planners and hotel broker companies in order to diminish redundancy and reduce mistakes. Needless to say, Internet access and good Wi-Fi in hotels are a must! (still, many event attendees complain about this regularly).

 

Managing Accommodation Contracts (oldie but goldie)

accommodation.png

This is something that’s very familiar to old industry players. However, for those who are new in the business event sector, negotiating a contract with a hotel or venue is no easy thing. Hotel groups provide different contracts and signing the contract without really understanding what each and every sentence means can be a recipe for a big failure. PCOs and anybody signing venue contracts should read them carefully and if they have any doubts get legal advice before signing them. Also, they should establish their own clauses. An example would have to do with the venue being forbidden to advertise cheaper rooms than the contracted block, over the same period of time, without extending the lower rate to the block.

Some best practices when managing accommodation contracts would be:

  • Thoroughly read and understand contract terms.
  • Be very careful with your expected numbers, as over-inflation is not going to do anyone any good while underestimating the number of rooms may force you to find additional spaces elsewhere.
  • Make sure that room rate protection is included so that you have competitive room rates.
  • Include all financial liabilities in the contract.
  • Maintain a constant communication with all parties involved.

cb-01

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses, regardless of their location. The biggest congresses this year are:

All You Need to Know about The European Hematology Association and its Annual Congress

The European Hematology Association (EHA) was founded in Belgium in 1992. For the next 6 years, the Association organised a congress in different European cities every two years. Starting 1998, the congress became an annual event taking place in June. Nowadays, the Association’s executive office is located in the Netherlands, with over 3,200 members from 100 countries.

The educational program of the annual congress is based on the European Hematology Curriculum, the main goal of the Association being to lobby for hematology and promote research that supports hematologists in- and outside Europe.

Is the Annual Congress of the European Hematology Association on your list in 2017 or/ and 2018? Give us a sign and we’ll handle your accommodation needs in a fast and reliable way!

For 2017.

For 2018.

 

The Annual Congress

At the EHA Annual Congress, hematologists and affiliated professionals gain access to original unpublished data and ideas regarding hematological innovation. During the congress, they will be able to improve their knowledge and approach regarding evidence-based diagnosis and treatment diseases related to hematology, access research results on hematologic disorders, gain insight about innovative techniques and diagnostic tools, as well as leverage networking opportunities with other medical professionals, patient groups, medical industry and the media.

Besides a program that covers every subspecialty in hematology, the Annual EHA Congress gives attendees the opportunity to network with experts from across the globe. The congress also provides the opportunity to attend satellite programs, updates-in-hematology and to visit the exhibition put together by big pharmaceutical companies.

Between 22-25 June 2017, the EHA is organizing its annual congress in Madrid, Spain. The program will cover 15 tracks as follows: advocacy track, benign hematology, biology, clinical, early career track, general skills, laboratory diagnosis, lymphoid malignancies and plasma cell disorders, myeloid malignancies, pediatric hematology, personalised medicine, stem cell transplantation and special therapy, thrombosis and hemostasis, transfusion medicine, and translational. For a more detailed breakdown of each track, visit this page on their website.

There are 17 sessions that will be covered during this year’s annual congress: basic science in focus, clinical debate, early career session, education session, hematology-in-focus, joint symposium, laboratory diagnosis workshop, late breaking abstracts, meet-the-expert, molecular hemopoiesis workshop, oral presentation, plenary session, poster session, presidential symposium, satellite symposium, scientific working group, special session.

Make sure you know the key dates and other important information.

In 2018, the annual congress will take place in Stockholm, Sweden, between 14-17 June.

Apart from the annual congress, EHA also hosts other significant events meant to support hematologists and improve patient care.

 

Educational Events

Throughout the year, EHA organizes educational courses on the latest developments in hematology. These fall under two main categories: hematology tutorials and highlights of past EHA. In 2017, there is a tutorial on Lymphoid Malignancies in Warsaw, Poland, between 17-18 March and one on Laboratory Hematology between 8-9 April in Çanakkale, Turkey.

The Highlights of Past EHA event will take place in Cairo, Egypt, between 14-16 September 2017. This year, EHA-HOPE, short for Highlights of Past EHA, aims to bring the key messages from various fields of hematology of the 22nd Congress of EHA to the Middle East and North Africa.

 

Scientific Events

The EHA-SWG Scientific Meetings represent a joint collaboration between the EHA Scientific Working Groups (SWGs) and EHA. The meetings aim to provide an innovative format that includes e.g. discussions with patient organizations, regulators and pharma companies.

In 2017, there will be 4 big scientific meetings:

  • The EHA-SWG Scientific Meeting on Rare Lymphomas between 10-12 March, in Barcelona, Spain.
  • The EHA-SWG Scientific Meeting on Aging and Hematology.
  • The EHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms between 12-14 October, 2017.
  • EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy between 23-25 November, 2017.

Contact us for a personalised accommodation offer for the Annual Congress of the European Hematology Association. No strings attached. We usually reply within a few hours.

For 2017.

For 2018.

cb-01

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses, regardless of their location.

February’s Top Pharma News & Developments

These are last month’s pharma news and developments brought to you by Congress Bookers, a reliable accommodation partner for lead pharma companies worldwide.

 

AstraZeneca entered agreement with TerSera Therapeutics for Zoladex

astrazeneca-svg

AstraZeneca entered an agreement with TerSera Therapeutics LLC for the commercial rights to Zoladex in the US and Canada. Zoladex is used to treat prostate cancer, breast cancer and several benign gynaecological disorders.

Under the agreement, TerSera is set to pay AstraZeneca USD 250 million upfront, plus USD 70 million in sales-related milestones and a quarterly share of sales in the “mid-teen percentage” range. AstraZeneca will also develop and supply Zoladex to TerSera.

 

Novo Nordisk filed for regulatory approval of semaglutide for the treatment of type 2 diabetes in Japan

novo_nordisk-logo

Novo Nordisk has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare for semaglutide, a new glucagon-like peptide-1 analogue for the treatment of adults with type 2 diabetes.

This move follows the recent once-weekly semaglutide regulatory submissions to the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), Health Canada and SwissMedic.

 

Allergan Launched See America

allergan_logo_tm

Allergan launched a new initiative dubbed See America, through which it aims to make vision health a priority for all US residents. Increasing awareness of the diseases that can cause blindness and enhancing access to vision care for those who need it most are the initiative’s main focus.

The launch followed the release of a report published by the National Academies of Sciences, Engineering, and Medicine (NASEM), which stressed upon the overwhelming number of Americans affected by blindness from preventable causes.

 

Amgen’s Parsabiv got FDA approval

2000px-amgen-svg

The US Food and Drug Administration (FDA) approved Amgen’s Parsabiv (etelcalcetide) for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis.

Parsabiv is the first therapy approved for this condition in 12 years. It is also the only calcimimetic that can be administered intravenously three times a week after the hemodialysis session.

 

Roche to start second late-stage study of Alzheimer’s disease drug

roche

Roche’s partner AC Immune revealed that Roche is set to launch a second Phase III study of the experimental Alzheimer’s disease therapy crenezumab. The latter was discovered by AC Immune and out-licensed to Roche’s Genentech unit in 2006. The CREAD2 trial will enrol 750 patients with prodromal or mild Alzheimer’s disease.

 

Boehringer Ingelheim’s Giotrif got approved for lung cancer in China

boehringer_ingelheim_logo-svg

Global pharmaceutical company Boehringer Ingelheim announced that their afatinib (Giotrif), an irreversible second-generation ErbB family blocker, was approved for lung cancer in China.

Afatinib has received Imported Drugs License (IDL) status by the China Food and Drug Administration (CFDA) for locally advanced or metastatic EGFR mutation-positive lung cancer patients who have not received any prior therapy with tyrosine kinase inhibitors, as well as for patients with locally advanced or metastatic squamous cell carcinoma of the lung whose disease has progressed on or after treatment with platinum-based chemotherapy.

Afatinib is the first and only second-generation ErbB family blocker approved in China.

cb-01

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2017, regardless of their location. The biggest congresses next year are:

  • EHA 2017 – 445 rooms in fourteen 4-star hotels
  • ESMO 2017 – 440 rooms in ten 4-star hotels
  • ESC 2017 – 150 rooms in five 4-star hotels
  • EURETINA 2017 – 160 rooms in five 4-star hotels
  • EASD 2017 – 423 rooms in thirteen 4-star hotels
  • EAACI 2017 – 688 rooms in fourteen 4-star hotels